The trading price of Atyr Pharma Inc (NASDAQ:ATYR) closed lower on Monday, May 05, and closing at $3.58, -0.56% lower than its previous close.
Traders who pay close attention to intraday price movement should know that it fluctuated between $3.445 and $3.65. In examining the 52-week price action we see that the stock hit a 52-week high of $4.66 and a 52-week low of $1.42. Over the past month, the stock has gained 28.32% in value.
Atyr Pharma Inc, whose market valuation is $318.11 million at the time of this writing, is expected to release its quarterly earnings report on 2025-Mar-12. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by -0.18 per share this quarter, however they have predicted annual earnings per share of -0.71 for current year and -0.6 for next year.
From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue is 2M.
On the technical side, indicators suggest ATYR has a Hold on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Buy, while an average of long term indicators suggests that the stock is currently 100% Buy.
A quick review shows that ATYR’s price is currently 11.91% off the SMA20 and 7.07% off the SMA50. The RSI metric on the 14-day chart is currently showing 58.61, and weekly volatility stands at 6.67%. When measured over the past 30 days, the indicator reaches 9.40%. Atyr Pharma Inc (NASDAQ:ATYR)’s beta value is currently sitting at 0.79, while the Average True Range indicator is currently displaying 0.26.
To see how Atyr Pharma Inc stock has been performing in comparison to its peers in the industry, here are the numbers: ATYR stock’s performance was -0.56% in the latest trading, and 125.16% in the past year.
An evaluation of the daily trading volume of Atyr Pharma Inc (NASDAQ:ATYR) indicates that the 3-month average is 1.48 million. However, this figure has increased over the past 10 days to an average of 1.07.
Currently, records show that 88.86 million of the company’s shares remain outstanding. The insiders hold 3.22% of outstanding shares, whereasinstitutions hold 62.66%. The stats also highlight that short interest as of 2025-04-15, stood at 10.03 million shares, resulting in a short ratio of 7.01 at that time. From this, we can conclude that short interest is 1377.00 of the company’s total outstanding shares. It is noteworthy that short shares in April were up slightly from the previous month’s figure, which was 6.92 million. However, since the stock’s price has seen -1.10% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
